• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于药代动力学中鲁棒模型降阶的方法。

A method for robust model order reduction in pharmacokinetics.

机构信息

School of Pharmacy, University of Athens, Panepistimiopolis, Athens, 157 71, Greece.

出版信息

J Pharmacokinet Pharmacodyn. 2009 Dec;36(6):613-28. doi: 10.1007/s10928-009-9141-9. Epub 2009 Nov 20.

DOI:10.1007/s10928-009-9141-9
PMID:19936895
Abstract

We present a Bayesian automated method to reduce by lumping, a large system described by differential equations which takes into account parameter variability. Model reduction is a potentially useful tool to simplify large systems but suffers from lack of robustness over the model parameter values. With the present method we address this problem by incorporating a prior parameter distribution in the determination of the optimal lumping scheme in a Bayesian manner. Applications of this method may include PBPK models for the drug distribution and/or Systems Biology models for the drug action. The method builds on our previously published algorithm for lumping that works stepwise, reducing the system's dimension by one at each step and where each successive step is conditional to the previous ones. We applied the methodology to a PBPK model for barbiturates taken from the literature. An arbitrary variability of 20% CV was added to the nominal reported parameter values. The Bayesian method performed better than the method which ignored the parameter variability, producing a lumping scheme which, while not optimal for any parameter value, was optimal on average. On the other hand the simple, non-Bayesian method produced a lumping scheme which while optimal for the nominal parameter values, was very poor for most other values within the prior distribution. Further, we discuss the generality of a lumping strategy to reduce a model and we argue that this is more powerful than elimination of states, with the latter being almost a special case of lumping.

摘要

我们提出了一种贝叶斯自动化方法,通过聚类来减少由微分方程描述的、考虑参数可变性的大型系统。模型简化是简化大型系统的一种潜在有用工具,但在模型参数值方面缺乏稳健性。通过本方法,我们通过以贝叶斯方式将先验参数分布纳入最优聚类方案的确定中,解决了这个问题。这种方法的应用可能包括药物分布的 PBPK 模型和/或药物作用的系统生物学模型。该方法基于我们之前发表的逐步聚类算法,每次减少系统的一个维度,每个后续步骤都依赖于前一个步骤。我们将该方法应用于文献中提取的巴比妥酸盐 PBPK 模型。将名义报告参数值的任意 20%CV 变异性添加到模型中。贝叶斯方法的性能优于忽略参数可变性的方法,产生的聚类方案虽然不是针对任何参数值最优,但平均来说是最优的。另一方面,简单的非贝叶斯方法产生的聚类方案虽然针对名义参数值是最优的,但对于先验分布中的大多数其他值,效果很差。此外,我们还讨论了简化模型的聚类策略的通用性,并认为这比消除状态更有效,后者几乎是聚类的一个特例。

相似文献

1
A method for robust model order reduction in pharmacokinetics.一种用于药代动力学中鲁棒模型降阶的方法。
J Pharmacokinet Pharmacodyn. 2009 Dec;36(6):613-28. doi: 10.1007/s10928-009-9141-9. Epub 2009 Nov 20.
2
Proper lumping in systems biology models.系统生物学模型中的合理归并。
IET Syst Biol. 2009 Jan;3(1):40-51. doi: 10.1049/iet-syb:20070055.
3
Lumping of whole-body physiologically based pharmacokinetic models.基于生理药代动力学的全身模型整合
J Pharmacokinet Biopharm. 1998 Feb;26(1):21-46. doi: 10.1023/a:1023272707390.
4
Reduction of a Whole-Body Physiologically Based Pharmacokinetic Model to Stabilise the Bayesian Analysis of Clinical Data.简化基于生理的全身药代动力学模型以稳定临床数据的贝叶斯分析
AAPS J. 2016 Jan;18(1):196-209. doi: 10.1208/s12248-015-9840-7. Epub 2015 Nov 4.
5
Lumping in pharmacokinetics.药代动力学中的归并。
J Pharmacokinet Pharmacodyn. 2005 Dec;32(5-6):719-36. doi: 10.1007/s10928-005-0054-y.
6
An efficient Bayesian kinetic lumping algorithm to identify metastable conformational states via Gibbs sampling.一种高效的贝叶斯动力学集总算法,通过吉布斯采样来识别亚稳态构象状态。
J Chem Phys. 2018 Aug 21;149(7):072337. doi: 10.1063/1.5027001.
7
Automated proper lumping for simplification of linear physiologically based pharmacokinetic systems.用于简化基于生理药代动力学线性系统的自动合理归并
J Pharmacokinet Pharmacodyn. 2019 Aug;46(4):361-370. doi: 10.1007/s10928-019-09644-5. Epub 2019 Jun 21.
8
Reduction and lumping of physiologically based pharmacokinetic models: prediction of the disposition of fentanyl and pethidine in humans by successively simplified models.基于生理的药代动力学模型的简化与归并:通过逐步简化模型预测芬太尼和哌替啶在人体内的处置情况
J Pharmacokinet Pharmacodyn. 2003 Aug;30(4):285-307. doi: 10.1023/a:1026194618660.
9
A combined model reduction algorithm for controlled biochemical systems.一种用于受控生化系统的组合模型约简算法。
BMC Syst Biol. 2017 Feb 13;11(1):17. doi: 10.1186/s12918-017-0397-1.
10
Lumping analysis for the prediction of long-time dynamics: from monomolecular reaction systems to inherent structure dynamics of glassy materials.聚团分析在长时间动力学预测中的应用:从单分子反应体系到玻璃态材料的本征结构动力学。
J Chem Phys. 2011 Nov 28;135(20):204507. doi: 10.1063/1.3663207.

引用本文的文献

1
Model reduction and analysis: A case study of a malaria control model.模型简化与分析:疟疾控制模型的一个案例研究
medRxiv. 2025 Aug 26:2025.08.21.25334195. doi: 10.1101/2025.08.21.25334195.
2
A minimal PBPK model to accelerate preclinical development of drugs against tuberculosis.一种用于加速抗结核药物临床前开发的最小化生理药代动力学(PBPK)模型。
Front Pharmacol. 2024 Jan 4;14:1272091. doi: 10.3389/fphar.2023.1272091. eCollection 2023.
3
Deriving mechanism-based pharmacodynamic models by reducing quantitative systems pharmacology models: An application to warfarin.

本文引用的文献

1
The subtle business of model reduction for stochastic chemical kinetics.随机化学动力学模型约简的精细过程。
J Chem Phys. 2009 Feb 14;130(6):064103. doi: 10.1063/1.3072704.
2
Proper lumping in systems biology models.系统生物学模型中的合理归并。
IET Syst Biol. 2009 Jan;3(1):40-51. doi: 10.1049/iet-syb:20070055.
3
Finding multiple target optimal intervention in disease-related molecular network.在疾病相关分子网络中寻找多个靶点的最优干预
通过简化定量系统药理学模型来推导演化药理学模型:以华法林为例。
CPT Pharmacometrics Syst Pharmacol. 2023 Apr;12(4):432-443. doi: 10.1002/psp4.12903. Epub 2023 Mar 3.
4
Investigation of simplified physiologically-based pharmacokinetic models in rat and human.简化生理药代动力学模型在大鼠和人体中的研究。
CPT Pharmacometrics Syst Pharmacol. 2023 Mar;12(3):333-345. doi: 10.1002/psp4.12911. Epub 2023 Feb 8.
5
Automated proper lumping for simplification of linear physiologically based pharmacokinetic systems.用于简化基于生理药代动力学线性系统的自动合理归并
J Pharmacokinet Pharmacodyn. 2019 Aug;46(4):361-370. doi: 10.1007/s10928-019-09644-5. Epub 2019 Jun 21.
6
Model reduction in mathematical pharmacology : Integration, reduction and linking of PBPK and systems biology models.数学药理学中的模型简化:PK/PD 模型和系统生物学模型的整合、简化和链接。
J Pharmacokinet Pharmacodyn. 2018 Aug;45(4):537-555. doi: 10.1007/s10928-018-9584-y. Epub 2018 Mar 26.
7
Understanding and reducing complex systems pharmacology models based on a novel input-response index.基于新型输入-响应指标理解和简化复杂系统药理学模型。
J Pharmacokinet Pharmacodyn. 2018 Feb;45(1):139-157. doi: 10.1007/s10928-017-9561-x. Epub 2017 Dec 14.
8
Development of a Novel Simplified PBPK Absorption Model to Explain the Higher Relative Bioavailability of the OROS® Formulation of Oxybutynin.开发一种新型简化的生理药代动力学吸收模型以解释奥昔布宁OROS®制剂更高的相对生物利用度。
AAPS J. 2016 Nov;18(6):1532-1549. doi: 10.1208/s12248-016-9965-3. Epub 2016 Sep 8.
9
Reduction of a Whole-Body Physiologically Based Pharmacokinetic Model to Stabilise the Bayesian Analysis of Clinical Data.简化基于生理的全身药代动力学模型以稳定临床数据的贝叶斯分析
AAPS J. 2016 Jan;18(1):196-209. doi: 10.1208/s12248-015-9840-7. Epub 2015 Nov 4.
10
Application of a Bayesian approach to physiological modelling of mavoglurant population pharmacokinetics.贝叶斯方法在吗啉硝唑群体药代动力学生理模型中的应用。
J Pharmacokinet Pharmacodyn. 2015 Dec;42(6):639-57. doi: 10.1007/s10928-015-9430-4. Epub 2015 Aug 1.
Mol Syst Biol. 2008;4:228. doi: 10.1038/msb.2008.60. Epub 2008 Nov 4.
4
Robust simplifications of multiscale biochemical networks.多尺度生化网络的稳健简化
BMC Syst Biol. 2008 Oct 14;2:86. doi: 10.1186/1752-0509-2-86.
5
Reducing whole body physiologically based pharmacokinetic models using global sensitivity analysis: diazepam case study.
J Pharmacokinet Pharmacodyn. 2006 Feb;33(1):1-27. doi: 10.1007/s10928-005-0004-8. Epub 2005 Dec 20.
6
Lumping in pharmacokinetics.药代动力学中的归并。
J Pharmacokinet Pharmacodyn. 2005 Dec;32(5-6):719-36. doi: 10.1007/s10928-005-0054-y.
7
Simplification of Mathematical Models of Chemical Reaction Systems.化学反应系统数学模型的简化
Chem Rev. 1998 Apr 2;98(2):391-408. doi: 10.1021/cr950223l.
8
Lumping of whole-body physiologically based pharmacokinetic models.基于生理药代动力学的全身模型整合
J Pharmacokinet Biopharm. 1998 Feb;26(1):21-46. doi: 10.1023/a:1023272707390.
9
Quantitative structure-pharmacokinetics relationships: I. Development of a whole-body physiologically based model to characterize changes in pharmacokinetics across a homologous series of barbiturates in the rat.定量构效关系:I. 构建一个基于生理学的全身模型以表征大鼠体内一系列同系巴比妥类药物的药代动力学变化
J Pharmacokinet Biopharm. 1997 Jun;25(3):277-312. doi: 10.1023/a:1025771608474.